Alcresta Therapeutics - Ownership and Business Overview

Life ScienceCompany

Alcresta Therapeutics Ownership

Who owns Alcresta Therapeutics?

Alcresta Therapeutics is owned by Linden Capital Partners. It was acquired on March 12, 2024.

Is Alcresta Therapeutics PE-backed?

Yes. Alcresta Therapeutics is owned by private equity investor Linden Capital Partners.

Was Alcresta Therapeutics formerly PE-backed?

Yes. Alcresta Therapeutics was formerly owned by 2 private investors.

Alcresta Therapeutics Business Overview

Where is Alcresta Therapeutics headquartered?

Alcresta Therapeutics is headquartered in Newton, Massachusetts.

What sector is Alcresta Therapeutics in?

Alcresta Therapeutics is a life science company.

When was Alcresta Therapeutics founded?

Alcresta Therapeutics was founded in 2011.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 153 acquisitions of life science companies in 2024, including 13 acquisitions by private equity firms, and 140 by strategics.

Alcresta Therapeutics

Alcresta Therapeutics, Inc.

One Newton Executive Park, Suite 100,
Newton, Massachusetts 02462
United States,
(617) 431-3600
www.alcresta.com

Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long-chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients. Alcresta Therapeutics was formed in 2011 and is based in Newton, Massachusetts.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.